The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability

被引:56
|
作者
Lazarski, Christopher A.
Chaves, Francisco A.
Sant, Andrea J.
机构
[1] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[3] Univ Chicago, Comm Immunol, Dept Biol Sci, Chicago, IL 60637 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2006年 / 203卷 / 05期
关键词
D O I
10.1084/jem.20060058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DM edits the peptide repertoire presented by major histocompatibility complex class II molecules by professional antigen-presenting cells (APCs), favoring presentation of some peptides over others. Despite considerable research by many laboratories, there is still significant uncertainty regarding the biochemical attributes of class II - peptide complexes that govern their susceptibility to DM editing. Here, using APCs that either do or do not express DM and a set of unrelated antigens, we found that the intrinsic kinetic stability of class II - peptide complexes is tightly correlated with the effects of DM editing within APCs. Furthermore, through the use of kinetic stability variants of three independent peptides, we demonstrate that increasing or decreasing the kinetic stability of class II - peptide complexes causes a corresponding alteration in DM editing. Finally, we show that the spontaneous kinetic stability of class II complexes correlates directly with the efficiency of presentation by DM+ APCs and the immunodominance of that class II - peptide complex during an immune response. Collectively, these results suggest that the pattern of DM editing in APCs can be intentionally changed by modifying class II - peptide interactions, leading to the desired hierarchy of presentation on APCs, thereby promoting recruitment of CD4 T cells specific for the preferred peptides during an immune response.
引用
收藏
页码:1319 / 1328
页数:10
相关论文
共 50 条
  • [31] The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway
    Schulze, Monika-Sarah E. D.
    Wucherpfennig, Kai W.
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (01) : 105 - 111
  • [32] Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8+ T-cell response
    Knittel, Delphine
    Gadzinski, Adeline
    Hua, Stephane
    Denizeau, Jordan
    Savatier, Alexandra
    de la Rochere, Philippe
    Boulain, Jean-Claude
    Amigorena, Sebastian
    Piaggio, Eliane
    Sedlik, Christine
    Leonetti, Michel
    VACCINE, 2016, 34 (27) : 3093 - 3101
  • [33] Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation
    Birkholz, Katrin
    Schwenkert, Michael
    Kellner, Christian
    Gross, Stefanie
    Fey, Georg
    Schuler-Thurner, Beatrice
    Schuler, Gerold
    Schaft, Niels
    Doerrie, Jan
    BLOOD, 2010, 116 (13) : 2277 - 2285
  • [34] MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity
    Irla, Magali
    Kuepfer, Natalia
    Suter, Tobias
    Lissilaa, Rami
    Benkhoucha, Mahdia
    Skupsky, Jonathan
    Lalive, Patrice H.
    Fontana, Adriano
    Reith, Walter
    Hugues, Stephanie
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (09): : 1891 - 1905
  • [35] Catalysis of peptide dissociation from class II MHC-peptide complexes
    Schmitt, L
    Kratz, JR
    Davis, MM
    McConnell, HM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6581 - 6586
  • [36] Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome
    Dissanayake, SK
    Tuera, N
    Ostrand-Rosenberg, S
    JOURNAL OF IMMUNOLOGY, 2005, 174 (04): : 1811 - 1819
  • [37] Disruption of the MHC class II restricted antigen presentation pathway by vaccinia virus
    Li, P
    Brutkiewicz, RR
    Blum, JS
    FASEB JOURNAL, 2003, 17 (07): : C307 - C307
  • [38] The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding
    Huard, R
    Dyall, R
    NikolicZugic, J
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (11) : 1701 - 1707
  • [39] Conformational isomers of a class II MHC-peptide complex in solution
    Schmitt, L
    Boniface, JJ
    Davis, MM
    McConnell, HM
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (01) : 207 - 218
  • [40] A closer look at proteolysis and MHC-class-II-restricted antigen presentation
    Lennon-Duménil, AM
    Bakker, AH
    Wolf-Bryant, P
    Ploegh, HL
    Lagaudrière-Gesbert, C
    CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (01) : 15 - 21